All In Biotech

Drug Trial Radar · NCT00660660

Local Phase IV, Gastroesophageal Reflux Disease (GERD) Sleep Study US

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment With Esomeprazole 20 mg qd to Placebo qd in Patients With Heartburn and Sleep Disturbances Associated With Gastroesophageal Reflux Disease (GERD)

Last checked: Nov 20, 2026Latest source record: Mar 2, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 276 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

276

Actual

Start

Apr 2008

Primary completion

Jul 2008

Study completion Jul 2008

Sponsor

Lead sponsor
AstraZenecaAstraZeneca (AZN)
Sponsor type
Industry
First posted
Apr 17, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this research study is to compare the safety and effectiveness (how well the medicine works) of esomeprazole (study drug) to placebo (a capsule that does not contain any medication) taken daily in relieving nighttime heartburn and problems sleeping in patients with gastroesophageal reflux disease (GERD).

Conditions

  • Gastroesophageal Reflux Disease

Interventions

  • EsomeprazoleDrug

    Nexium 20 mg administered once daily as 22.3 mg of esomeprazole magnesium hydrate

  • PlaceboDrug

    once daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Patients With Relief of Nighttime Heartburn During the Last 7 Days of the Study.Time frame: Days 21- 28 (for early dropouts the last 7 days staying in the study)

Locations

45 sites in 1 country. Site status is shown where the registry gives one.

  • Research Site

    Huntsville, Alabama

  • Research Site

    Tucson, Arizona

  • Research Site

    Little Rock, Arkansas

  • Research Site

    Anaheim, California

  • Research Site

    Burbank, California

  • Research Site

    Castro Valley, California

  • Research Site

    Orange, California

  • Research Site

    San Diego, California

  • Research Site

    Boynton Beach, Florida

  • Research Site

    Coral Springs, Florida

  • Research Site

    DeLand, Florida

  • Research Site

    Hollywood, Florida

  • Research Site

    Jupiter, Florida

  • Research Site

    Pembroke Pines, Florida

  • Research Site

    South Miami, Florida

  • Research Site

    Tampa, Florida

  • Research Site

    Zephyrhills, Florida

  • Research Site

    Stockbridge, Georgia

  • Research Site

    Overland Park, Kansas

  • Research Site

    Lexington, Kentucky

  • Research Site

    Hollywood, Maryland

  • Research Site

    Las Vegas, Nevada

  • Research Site

    Medford, New Jersey

  • Research Site

    Perth Amboy, New Jersey

  • Research Site

    West Orange, New Jersey

  • Research Site

    Albuquerque, New Mexico

  • Research Site

    Binghamton, New York

  • Research Site

    Huntersville, North Carolina

  • Research Site

    Raleigh, North Carolina

  • Research Site

    Winston-Salem, North Carolina

  • Research Site

    Cincinnati, Ohio

  • Research Site

    Dayton, Ohio

  • Research Site

    Kettering, Ohio

  • Research Site

    Oklahoma City, Oklahoma

  • Research Site

    Chattanooga, Tennessee

  • Research Site

    Johnson City, Tennessee

  • Research Site

    Amarillo, Texas

  • Research Site

    Fort Worth Dallas, Texas

  • Research Site

    Houston, Texas

  • Research Site

    Ogden, Utah

Showing 40 of 45 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.